IP Library › Granted Patent US 7,544,771
Granted Patent B2
US 7,544,771 · App. 11/064,109 · Granted Jun 9, 2009

Protein and its use in diagnosing Alzheimer's disease

Assignee: Nymox Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,771
App. No.
11/064,109
Granted
Jun 9, 2009
Kind
B2
Abstract

Embodiments are directed to a peptide and protein containing that peptide, nucleic acids, antibodies, as well assays detecting the peptide or protein, and methods of identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases.

Claims (7)

1. An isolated peptide consisting of the amino acid sequence of SEQ ID NO:14.

2. The peptide of claim 1 , wherein the peptide is substantially pure.

3. The peptide of claim 1 , wherein the peptide is a recombinant peptide.

4. An isolated peptide consisting of a peptide consisting of the amino acid sequence of SEO ID NO: 14 conjuated to a conjugating peptide consisting of the amino acid sequence of SEO ID NO: 12.

5. An isolated peptide encoded by the nucleic acid sequence consisting of SEQ ID NO:15.

6. A composition comprising an isolated peptide consisting of the amino acid sequence of SEQ ID NO:14.

7. The composition of claim 6 , additionally comprising a carrier.

Assignments (3)
CONDITIONAL ASSIGNMENT Recorded Oct 25, 2023
From: AVERBACK, PAUL
To: NYMOX CORPORATION
Reel/Frame 065344/0473 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: NYMOX CORPORATION
To: AVERBACK, PAUL
Reel/Frame 065316/0412 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2005
From: AVERBACK, PAUL; GEMMELL, JACK
To: NYMOX CORPORATION
Reel/Frame 016691/0121 →
Continuity (1)
Related Publication 20060188935A1 · Aug 24, 2006